coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Carnforth And Milnthorpe PCN, Westmorland and Furness (LAD) · Health Inequalities Profile

    PCN U50573 · NHS Lancashire and South Cumbria Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,842

    Registered population

    52.3% aged 18–64

    32.3%

    Aged 65+

    ICB 20.0% · England 17.9%

    0.7%

    Ethnic minority (non-White)

    0.1% Asian

    0.0%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    6,360

    Hypertension register

    +12.02% in 3 yrs · England +5.60%

    242

    SMI register

    11% of Westmorland and Furness (LAD)'s

    567

    COPD register

    Reviews -0.36% in 3 yrs

    Forecast to 2030

    8,269

    Hypertension patients, 2030

    +1,909 on today

    69.5%

    QRISK ≥20% on statins, 2030

    +4.95pp over 3 yrs

    8.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    58.2%
    Cardiovascular lipid therapy trails national and local benchmarks.

    Only 58.2% of patients with QRISK ≥ 20% receive lipid-lowering therapy (England 63.6%), alongside 68.5% hypertension treatment to target (England 70.3%).

    33.0 pp
    Phone access diverges sharply; 717 asthma patients unreviewed.

    GPPS phone access differs by 33.0 pp (Ash Trees Surgery 64.6%, Park View Surgery 97.6%), while 717 of 2,559 asthma patients lack an annual.

    +13.8%
    Diabetes HbA1c control and age-5 immunisations exceed England.

    Non-frail diabetes HbA1c control rose +13.8% from 2023 to 2025 to 57.9% (England +4.4%), while age-5 MMR2 coverage reached 97.5% (England 82.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ comprise 32.3% of registered patients, exceeding the England average of 17.9%

    Registered list size is 31,842 patients across Ash Trees Surgery (23,786) and Park View Surgery (8,056). Registered patients aged 65+ comprise 32.3% (10,276 patients), above Westmorland and Furness (LAD) (25.9%), NHS Lancashire and South Cumbria Integrated Care Board (20.0%) and England (17.9%). Ash Trees Surgery records 32.9% aged 65+, and Park View Surgery records 30.4%. Based on Census usual residents rather than registered patients, ethnicity is 99.3% White with a 0.7% ethnic minority share (Asian / Asian British 0.1%, Black / African / Caribbean / Black British 0.01%).

    Age profile

    0–1715.5%
    18–6452.3%
    65+32.3%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White99.3%
    Mixed0.5%
    Asian0.1%
    Other0.1%
    Black0.0%

    Older people · falls rows are Westmorland and Furness (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Westmorland and Furness LA)1,5912,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.9%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Westmorland and Furness LA)7361,0219552024/25
    Falls deaths, all ages, per 100,000 (Westmorland and Furness LA)10.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.7 with 0.0% of registered patients in Core20

    The PCN has an average IMD decile of 7.7, compared with 6.0 in Westmorland and Furness (LAD), 5.0 in NHS Lancashire and South Cumbria Integrated Care Board and 5.5 in England. Registered Core20 patients represent 0.0%, below the borough (9.2%), ICB (30.6%) and England (21.0%). At Ash Trees Surgery (decile 7.8) and Park View Surgery (decile 7.6), 0.0% of patients reside in Core20 deciles, yielding 0 estimated Core20 patients across 0 decile 2 LSOAs.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Ash Trees0.0% · 0 patients
    Park View0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    242

    SMI register

    0.76% recorded prevalence

    121

    Learning disability register

    0.38% recorded prevalence

    14

    Care homes, 407 beds

    In the PCN catchment

    Learning disability prevalence is 0.4% (121 patients), trailing Westmorland and Furness (LAD) (0.6%), NHS Lancashire and South Cumbria Integrated Care Board (0.6%) and England (0.6%). Severe mental illness records 242 patients (0.8%). Catchment care homes number 14 with 407 beds, while district rough sleeping in Westmorland and Furness was 14 in autumn 2025.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 78.2% (Ash Trees Surgery 76.7%, England 83.4%), falling 7.4 pp from 2023 to 2025 (England +4.4 pp). Alcohol recording was 64.5% (England 81.8%) and BMI checks 75.4% (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,360

    Hypertension register

    +12.02%

    Register growth, 3 yrs

    Westmorland and Furness (LAD) +6.93% · England +5.60%

    +4.85pp

    BP control, under 80

    ≤140/90 · +0.32pp aged 80+

    +1,909

    More patients by 2030

    Forecast 8,269 (25.01%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 19.9% (6,360 patients), exceeding England (15.2%), Westmorland and Furness (LAD) (18.2%) and NHS Lancashire and South Cumbria Integrated Care Board (17.2%), though crude rates are not age-adjusted. Blood pressure checks reach 91.2% (England 90.0%). However, treatment to target is 68.5% (England 70.3%, Westmorland and Furness (LAD) 71.7%), with Ash Trees Surgery at 66.7% and Park View Surgery at 75.2%. Control is 76.2% for patients aged 80+ (England 81.2%) and 65.4% for patients aged under 80 (England 67.8%). Blood pressure control trails national benchmarks despite high check rates, indicating potential benefit from targeted medication titration, particularly for patients aged 80 and over.

    Lipids and statins

    The PCN treats 58.2% of patients with QRISK ≥ 20% with lipid-lowering therapy, below England (63.6%) and Westmorland and Furness (LAD) (59.6%), alongside 63.3% of CKD patients (England 70.3%). Fewer high-risk patients receive lipid-lowering therapy than national rates indicate, showing an opportunity to review eligible cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202690,609£1.30£1.64£1.86£117,792
    Cardiovascular (all), 2025128,179£2.89£3.38£3.33£370,437

    In 2026, the PCN prescribed 90,609 lipid-regulating drug items at £1.30 per item (England £1.86, Westmorland and Furness (LAD) £1.68, NHS Lancashire and South Cumbria Integrated Care Board £1.64), spending £50,741 less than at England's unit cost. Lower unit cost than comparators does not establish efficiency, but confirms PCN spend per item sits below national rates.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    0.00%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.45%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 8.4% (2,559 patients), exceeding England (6.6%) and Westmorland and Furness (LAD) (7.9%). The review rate is 72.0% (England 65.7%), leaving an estimated 717 patients without a recorded review, while paediatric asthma prescribing is 1,942 items per 1,000 aged 5-19 (England 1,488). The 567-patient COPD register (1.8%) fell 7.2% from 2023 to 2025 (England +2.6%), though 83.8% received a review (England 76.4%). Prioritising unreviewed asthma patients and validating register trends across respiratory conditions remain key operational priorities.

    Cancer register and children's immunisation

    Cancer prevalence is 6.6% (2,103 patients), exceeding England (3.8%) and Westmorland and Furness (LAD) (5.3%). In Q1 2025/26 childhood immunisations, 6-in-1 coverage is below the 95.0% target by 2.9 pp at 12 months (92.1%) and by 5 pp at 24 months (90.0%), while age 5 coverage reaches 97.5% for MMR dose 2 and 95.0% for 4-in-1 booster. Infant course completion lags behind targets, showing a need for early scheduling.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.1%

    England 91.0%

    6-in-1 complete primary course at 24 months90.0%

    England 92.2%

    MMR dose 1 at 24 months93.3%

    England 88.3%

    MMR dose 2 at age 597.5%

    England 82.8%

    4-in-1 pre-school booster at age 595.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of staged cancers across NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2 (4,642 of 8,863 cases), below England (55.3%) and below the 75.0% national ambition by 22.6 pp. Across the ICB, reaching 75.0% would require about 2,010 additional early-stage diagnoses annually. Between 2013 and 2022, the ICB early-stage share fell 1.2 pp. Known-stage completeness was 74.6% (8,863 of 11,883 cancers), exceeding England (67.0%). These system figures describe ICB performance rather than PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), University Hospitals of Morecambe Bay NHS Foundation Trust recorded 78.4% on 28-day faster diagnosis and 72.4% on 62-day treatment, below the 85.0% standard by 12.6 pp (ICB 73.6%, England 71.2%). Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% and Lancashire Teaching Hospitals NHS Foundation Trust 75.0%. For diagnostic tests in July 2026, 10.4% waited 6+ weeks at University Hospitals of Morecambe Bay NHS Foundation Trust (Blackpool Teaching Hospitals NHS Foundation Trust 26.5%, Lancashire Teaching Hospitals NHS Foundation Trust 26.7%, England 23.1%). These provider figures do not measure PCN performance.

    Pathways within standard (%)of Morecambe BayBlackpoolLancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)78.3971.3882.9078.3979.32
    31-day treatment (96%)95.2297.9689.4393.6292.50
    62-day referral to treatment (85%)72.3567.4875.0473.6271.16
    Diagnostic waits over 6 weeks (%)of Morecambe BayBlackpoolLancashireEngland
    MRI4.0421.802.4121.40
    CT13.7616.4914.979.92
    Echocardiography10.557.5713.8528.48
    Colonoscopy0.6013.080.0030.83
    Gastroscopy1.4512.470.0029.02
    All 15 DM01 tests10.4426.5426.6523.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In June 2026 (provisional), Westmorland and Furness residents accounted for 249,980 community care activities and 53,485 care contacts, out of 533,345 activities and 193,720 contacts across NHS Lancashire and South Cumbria Integrated Care Board. Adults aged 65+ accounted for 67.9% of borough contacts (36,330). These experimental figures describe local authority resident activity rather than PCN registered patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access diverges by 33.0 pp across practices despite similarly high overall satisfaction

    In 2025/26, overall QOF achievement reached 94.0% at Ash Trees Surgery and 96.7% at Park View Surgery (England 92.5%). Clinical-domain achievement was 95.9% at Ash Trees Surgery and 99.5% at Park View Surgery. Vaccination and immunisation achievement was 74.5% at Park View Surgery, while achievement reached 75.0% at Ash Trees Surgery (a 0.4 pp range), with both exceeding England's 55.2%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Park View Surgery1070.097.6%67.7%85.1%
    Ash Trees Surgery1230.064.6%79.1%82.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWestmorland and Furness (LAD)AssetPCNWestmorland and Furness (LAD)
    Care homes (catchment)14 (407 beds)n/aSchools (catchment)37n/a
    Children's centres312Places of worship58316
    Libraries514Food banks (VCS)n/a2
    Day centres (VCS)n/a2Children and young people (VCS)n/a3
    Carers support groups (VCS)n/a2Primary schools (LA maintained)2082
    Primary academies227Special schools14

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma review and prescribing recall

    72.0% of the 2,559 asthma patients had a review (England 65.7%, LAD 70.4%), leaving an estimated 717 unreviewed. For discussion, the PCN could run structured asthma recall and inhaler checks across Ash Trees Surgery (23,786) and Park View Surgery (8,056). Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Learning disability register validation

    Learning disability prevalence is 0.4% (121 of 31,842 patients) versus 0.6% across LAD, ICB and England (+55 to +66 benchmark gap). For discussion, practices could audit diagnostic codes and cross-check social-care records where sharing exists across Ash Trees Surgery (23,786) and Park View Surgery (8,056). Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Option 3

    COPD register and spirometry review

    COPD prevalence is 1.8% (567 of 31,842 patients) versus 1.9% in England and 2.0% in LAD (+36 to +75 benchmark gap). For discussion, practices could search for symptomatic smokers with repeat inhalers lacking a code and raise spirometry access with system partners. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register audit (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Clinical register vulnerability outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health review recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension medication titration review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Early infant immunisation recall (p6)6-in-1 complete primary course at 24 months10YHP sickness to prevention · 95% targetPCN
    System early diagnosis audit (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Telephony access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Asthma review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Learning disability register validation (p12)Registered population · Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Option 3 · COPD register and spirometry review (p12)Registered population · COPD register · COPD: QOF prevalenceCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15